SC
Subhajit Chatterjee
About Subhajit Chatterjee
Data last updated:
Subhajit Chatterjee is a Director at Becura Lifesciences India Private Limited (since 2023) and Designated Partner at On9syndrome Media Labs Llp (since 2024). The companies operate in Healthcare. The largest current company by reported revenue is Becura Lifesciences India Private Limited at ₹53.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Jun 2023 | 2023 | ₹53.1 Lakh (FY 2025) | Active | |
| Designated Partner | 29 May 2024 | 2024 | Active |
Board colleagues of Subhajit Chatterjee
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lokesh Khurana | 11100712 | Becura Lifesciences India Private Limited | Director |
| Vineet Anand | 08283030 | Becura Lifesciences India Private Limited | Director |
| Aditiya Ashat | 10646959 | On9syndrome Media Labs Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhajit Chatterjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhajit Chatterjee
Subhajit Chatterjee currently holds 2 directorships: Becura Lifesciences India Private Limited (Director, since 12 Jun 2023, revenue ₹53.1 Lakh (FY 2025)); On9syndrome Media Labs Llp (Designated Partner, since 29 May 2024).
Subhajit Chatterjee was first appointed on 12 Jun 2023 as Director at Becura Lifesciences India Private Limited. The most recent appointment on record is 29 May 2024 at On9syndrome Media Labs Llp.
The current boards of Subhajit Chatterjee's companies include Lokesh Khurana (Becura Lifesciences India Private Limited), Vineet Anand (Becura Lifesciences India Private Limited), Aditiya Ashat (On9syndrome Media Labs Llp).